Anti-Human IgG Fc C-terminus Monoclonal Antibody1vial

6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile, 97.0%, 250mg

2-Methyl-5-(pyridin-4-yl)-1,3,4-oxadiazole, 95+%, 250mg

3-Bromo-n-methyl-5-nitropyridin-4-amine, 95+%, 500mg

5-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-1H-1,2,3-benzotriazole-6-carboxamide hydrochloride, 95+%, 25g

2-(Trifluoromethyl)thiazole-4-carbaldehyde, 95.0%, 250mg

Acide 2-amino-4-chlorobenzoïque, min 98 %, pour la biochimie, 25 g, emballage plastique.

Ethyl 3-hydrazinobenzoate hydrochloride, 95.0%, 500mg

Diéthylamine, min 99,5 %, pour la synthèse, 2,5 L, emballage en verre

2-Fluoro-3-trifluoromethyl-pyrazine, 95.0%, 1g

(S)-TETRAHYDROFURAN-3-YL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYL-3-(PHOSPHONOOXY)BUTAN-2-YL)CARBAMATE, 99%, 25mg

Thiosulfate de sodium pentahydrate 99 +%, pur 500 gramme

MOXIFLOXACIN, 95%, 250mg